Adipokines, inflammation, and the endothelium in diabetes

被引:170
作者
Waleed Aldhahi
Osama Hamdy
机构
[1] Joslin Diabetes Center, Boston, MA 02215, One Joslin Place
关键词
Insulin Resistance; Adipose Tissue; Endothelial Function; Subcutaneous Adipose Tissue; Troglitazone;
D O I
10.1007/s11892-003-0020-2
中图分类号
学科分类号
摘要
Cytokines are biologically active low molecular weight proteins that possess several endocrine and metabolic functions and are known products of the immune system and inflammation. Several of these cytokines were shown to be independent risk factors for cerebrovascular and coronary artery disease. Because visceral and subcutaneous adipose tissues are the major sources of cytokines (adipokines), increased adipose tissue mass is associated with alteration in adipokine production (eg, overexpression of tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6], plasminogen activator inhibitor-1 [PAI-1), and underexpression of adiponectin in adipose tissue). The proinflammatory status associated with these changes provides a potential link between insulin resistance and endothelial dysfunction, the early stage in the atherosclerotic process, in obese individuals, and in type 2 diabetic patients. Reduction of adipose tissue mass through weight reduction in association with exercise reduces TNF-α, IL-6, and PAI-1, increases adiponectin, and is associated with improved insulin sensitivity and endothelial function. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:293 / 298
页数:5
相关论文
共 63 条
  • [1] Flegal K.M., Carroll M.D., Ogden C.L., Johnson C.L., Prevalence and trends in obesity among US adults, 1999-2000, JAMA, 288, pp. 1723-1727, (2000)
  • [2] Balkau B., Eschwege E., Papoz L., Et al., Risk factors for early death in non-insulin dependent diabetes and men with known glucose intolerance status, BMJ, 307, pp. 295-299, (1993)
  • [3] Bergman R.N., Mittelman S.D., Central role of the adipocyte in insulin resistance, J. Basic Clin. Physiol. Pharmacol., 9, pp. 205-221, (1998)
  • [4] Saltiel A.R., You are what you secrete, Nat. Med., 7, pp. 887-888, (2001)
  • [5] Coppack S.W., Pro-inflammatory cytokines and adipose tissue, Proc. Nutr. Soc., 60, pp. 349-356, (2001)
  • [6] Mohamed-Ali V., Goodrick S., Bulmer K., Et al., Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo, Am. J. Physiol., 277, 6 PART 1, (1999)
  • [7] Hotamisligil G.S., Arner P., Caro J.F., Et al., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance, J. Clin. Invest., 95, pp. 2409-2415, (1995)
  • [8] Arner P., Regional differences in protein production by human adipose tissue, Biochem. Soc. Trans., 29, PART 2, pp. 72-75, (2001)
  • [9] Mohamed-Ali V., Goodrick S., Rawesh A., Et al., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo, J. Clin. Endocrinol. Metab., 82, pp. 4196-4200, (1997)
  • [10] Scherer P.E., Williams S., Fogliano M., Et al., A novel serum protein similar to C1q, produced exclusively in adipocytes, J. Biol. Chem., 270, pp. 26746-26749, (1995)